Is FBIO or GANX more profitable?

FBIO runs the higher net margin — FBIO at 163.32% versus GANX at 0.00%.

How have FBIO and GANX total returns compared?

Over the past 5 years, FBIO delivered -46.06% and GANX delivered -25.06% annualized total return. Past performance doesn't predict future results.

Fortress Biotech, Inc. (FBIO) vs Gain Therapeutics, Inc. (GANX)

A side-by-side comparison of Fortress Biotech, Inc. and Gain Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

FBIO

Fortress Biotech, Inc.

$68M

$2.06HealthcareDelayed quote: Oct 6, 2026, 11:25 AM EDT

GANX

Gain Therapeutics, Inc.

$74M

$1.74HealthcareDelayed quote: Oct 6, 2026, 11:25 AM EDT

Total return — FBIO vs GANX

growth of $100 · dividends reinvested · last 6y

FBIO -96.7% (-43.3%/yr)GANX -84.9% (-27.0%/yr)GANX compounded faster over this window

FBIO GANX

FBIO vs GANX: by the numbers

•GANX is the larger company ($74M vs $68M market cap).
•FBIO is profitable (163.32% net margin) while GANX runs a net loss (0.00%).

Metrics side by side

Valuation

Metric	FBIO	GANX
P/E ratio	0.77	N/A
P/S ratio	1.00	N/A
P/B ratio	0.42	6.55
FCF yield	183.89%	N/A

Profitability

Metric	FBIO	GANX
Gross margin	62.53%	0.00%
Operating margin	-111.00%	0.00%
Net margin	163.32%	0.00%
ROE	68.12%	-178.06%
ROIC	-10.85%	-159.24%

Growth (annualized)

Metric	FBIO	GANX
Revenue CAGR (5Y)	5.39%	N/A
Total return CAGR (5Y)	-46.06%	-25.06%

Frequently asked

Is FBIO or GANX more profitable?: FBIO runs the higher net margin — FBIO at 163.32% versus GANX at 0.00%.
How have FBIO and GANX total returns compared?: Over the past 5 years, FBIO delivered -46.06% and GANX delivered -25.06% annualized total return. Past performance doesn't predict future results.

Go deeper

Full FBIO analysis Full GANX analysis Interactive comparison tool

Dig into the metrics

Fortress Biotech P/E ratio Fortress Biotech ROE Gain Therapeutics ROE Fortress Biotech operating margin Gain Therapeutics operating margin Fortress Biotech revenue growth Gain Therapeutics revenue growth Fortress Biotech free cash flow Gain Therapeutics free cash flow

Fortress Biotech & Gain Therapeutics appear in these rankings

Highest ROE Stocks Highest FCF Yield Stocks Lowest P/E Ratio Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.